What: Axios reviews all the (manufactured) abortion pill controversies Marty Makary, the newly confirmed FDA commissioner, will face now that he is leading the agency–including the drama that led to his first pick for a top lawyer at FDA to be scuttled.
Key Line: ‘Makary has already experienced firsthand what a lightning rod mifepristone is shaking out to be. His actions — or inactions — at the beginning of his tenure as FDA commissioner will likely only reinforce that lesson.’
Source: Axios
New report calls women’s health a $360B ‘ghost market’ full of unmet needs across menopause, sexual health, aging, and more.
Massive cuts eliminated federal maternal and child health divisions and forced out a key director.
The Daily Show co-creator uses satire to support abortion access and independent clinics.
The Trump administration has frozen federal family-planning grants, affecting groups like Planned Parenthood.
The Economist finds abortions have increased in some states *after* bans, thanks to telehealth and shield laws.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
Legislators push for regulation and oversight of anti-abortion pregnancy centers.
Researchers call for standardized criteria to assess dangerous placenta conditions.
Women who start menopause before age 40 may face faster cognitive decline.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
Study shows women over 70 who screened regularly were diagnosed earlier and had lower mortality.
The Trump administration ends the Pregnancy Risk Assessment Monitoring System (PRAMS), a long-standing CDC data tool.
Cosmo breaks down Botox alternatives—and why your injector matters most.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.
Cancer incidence among women continues to rise despite overall progress.
A major study ties maternal diabetes to neurodevelopmental issues in children.
Legislators push for regulation and oversight of anti-abortion pregnancy centers.
A class action lawsuit reveals dangerous conditions at one CPC, prompting ultrasound regulations.
A blood test may soon predict postpartum depression before symptoms arise.